Here, we describe a newly diagnosed HIV-1-infected patient, in whom shortly after the initiation of a darunavir- based regimen, the HIV-1 virus exclusively mutated in the cerebrospinal fluid (CSF), leading to an increase in CSF HIV-1 RNA load and neurological complaints.
References
1.
Panel on Antiretroviral Guidelines for Adults and Adolescents.Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. (Updated 2009. Accessed 12 April 2011.) Available from www.aidsinfo.nih.gov/contentfiles/adultandadolescentgl.pdf.
2.
ThompsonM.A., AbergJ.A., CahnP.Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society–USA Panel. JAMA2010; 304: 321–333.
3.
JohnsonV.A., Brun-VezinetF., ClotetB.Update of the drug resistance mutations in HIV-1: December 2009. Top HIV Med2009; 17: 138–145.
4.
YilmazA., IzadkhashtiA., PriceR.W.Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected individuals. AIDS Res Hum Retroviruses2009; 25: 457–461.
5.
BoomR., SolC.J., SalimansM.M., JansenC.L., Wertheim-van DillenP.M., van der NoordaaJ.Rapid and simple method for purification of nucleic acids. J Clin Microbiol1990; 28: 495–503.
6.
van der KuylA.C., ZorgdragerF., JurriaansS.Incidence of human immunodeficiency virus type 1 dual infections in Amsterdam, the Netherlands, during 2003-2007. Clin Infect Dis2009; 48: 973–978.
7.
Salazar-GonzalezJ.F., BailesE., PhamK.T.Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J Virol2008; 82: 3952–3970.
8.
CanestriA., LescureF., JaureguiberryS.Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. Clin Infect Dis2010; 50: 773–778.
9.
van LelyveldS.F., NijhuisM., BaatzF.Therapy failure following selection of enfuvirtide-resistant HIV-1 in cerebrospinal fluid. Clin Infect Dis2010; 50: 387–390.
10.
LetendreS., FitzSimonsC., EllisR.Correlates of CSF viral loads in 1221 volunteers of the CHARTER Cohort.17th Conference on Retroviruses and Opportunistic Infections. 16–19 February 2010, San Francisco, CA, USA. Abstract 172.
11.
LetendreS., Marquie-BeckJ., CapparelliE.Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol2008; 65: 65–70.